Outcomes of Allogeneic Stem Cell Transplant (Allo-SCT) for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) in Patients Older Than 75 Years: A Single Center Analysis

被引：0
|
作者：
Nath, Rajneesh [1 ]
Cerny, Jan [2 ]
Ramanathan, Muthalagu [3 ]
Zhou, Zheng [2 ]
Yu, Neng [4 ]
Raffel, Glen D. [5 ]
Bednarik, Jayde [6 ]
机构：
[1] Banner MD Anderson Canc Ctr, Div Hematol Oncol, BMT & Acute Leukemia Program, Gilbert, AZ USA
[2] Univ Massachusetts, Med Sch, Dept Med, Div Hematol Oncol, Worcester, MA USA
[3] Univ Massachusetts Mem Ctr, Div Hematol, Dept Internal Med, Worcester, MA USA
[4] UMass Mem Med Ctr, HLA Lab, Worcester, MA USA
[5] Univ Massachusetts Med Sch, Div Hematol Oncol, Worcester, MA USA
[6] UMass Mem Med Ctr, Worcester, MA USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.5875.5875
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5875
引用
下载
收藏
页数：5
相关论文
共 50 条
  • [1] Selinexor Maintenance Is Feasible and Tolerable after Allogeneic Stem Cell Transplant (allo-SCT) for Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
    Liu, Hongtao
    Artz, Andrew
    Larson, Richard A.
    Kosuri, Satyajit
    Stock, Wendy
    Bishop, Michael R.
    BLOOD, 2017, 130
  • [2] Allogeneic stem cell transplantation (allo-SCT) in patients with secondary acute myelogenous leukemia (AML) or high risk myelodysplastic syndromes (MDS)
    El-Cheikh, J
    Faucher, C
    Mohty, M
    Stoppa, AM
    Lafage-Pochitaloff, M
    Coso, D
    Moziconacci, MJ
    Bouabdallah, R
    Gastaut, JA
    Blaise, D
    Vey, N
    BLOOD, 2005, 106 (11) : 440B - 440B
  • [3] Decitabine in patients with relapsed acute myeloid leukemia (AML) after allogeneic stem cell transplantation (allo-SCT)
    Siddhartha Ganguly
    Manik Amin
    Clint Divine
    Omar S. Aljitawi
    Sunil Abhyankar
    Joseph P. McGuirk
    Annals of Hematology, 2013, 92 : 549 - 550
  • [4] Decitabine in patients with relapsed acute myeloid leukemia (AML) after allogeneic stem cell transplantation (allo-SCT)
    Ganguly, Siddhartha
    Amin, Manik
    Divine, Clint
    Aljitawi, Omar S.
    Abhyankar, Sunil
    McGuirk, Joseph P.
    ANNALS OF HEMATOLOGY, 2013, 92 (04) : 549 - 550
  • [5] Allogeneic Stem Cell Transplantation (SCT) for Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) in Elderly Patients (Older than 60 Years)
    Pohlen, Michele
    Groth, Christoph
    Sauer, Tim
    Goerlich, Dennis
    Mesters, Rolf
    Schliemann, Christoph
    Lenz, Georg
    Mueller-Tidow, Carsten
    Buechner, Thomas
    Berdel, Wolfgang E.
    Stelljes, Matthias
    BLOOD, 2015, 126 (23)
  • [6] ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) IN THE ELDERLY PATIENTS (AGE > 65 YEARS) WITH ACUTE MYELOID LEUKEMIA (AML) IS SAFE AND EFFECTIVE
    Jagadeesh, D.
    Cerny, J.
    Ramanathan, M.
    Raffel, G. D.
    Petrillo-Deluca, L.
    Tarrasky, N.
    Krumpe, L. M.
    Bednarik, J.
    Barton, B. A.
    Walsh, W., V
    Nath, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S292 - S292
  • [7] Allogeneic haematopoietic stem cell transplantation for elderly patients with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML): A single center analysis
    Katayama, Y.
    Iwato, K.
    Ohchi, T.
    Okatani, T.
    Imanaka, R.
    Kyo, K.
    Itagaki, M.
    Katsutani, S.
    Kyo, T.
    Asaoku, H.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S475 - S476
  • [8] Salvage Therapy with Hypomethylating Agents (HMA) and/or Lenalidomide (len) for Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Relapse Following Allogeneic Stem Cell Transplantation (allo-SCT)
    Singh, Meenu
    Dhakal, Binod
    Shrestha, Anuj
    Atallah, Ehab
    Carlson, Karen
    Pasquini, Marcelo C.
    Rein, Lisa
    Banerjee, Anjishnu
    Esselmann, Jean
    Ramirez, Sarah
    Zellner, Katie
    Essenmacher, Amber
    Hari, Parameswaran N.
    Michaelis, Laura C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S357 - S357
  • [9] Final Analysis of the Phase I/II Study of CC-486 (Oral Azacitidine) Maintenance Therapy after Allogeneic Stem Cell Transplantation (Allo-SCT) in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)
    de Lima, Marcos
    Oran, Betul
    Champlin, Richard E.
    Papadopoulos, Esperanza B.
    Giralt, Sergio A.
    Scott, Bart L.
    William, Basem M.
    Hetzer, Joel
    Hubbell, Becky
    Skikne, Barry S.
    Craddock, Charles
    BLOOD, 2017, 130
  • [10] Impact of disease burden at time of allogeneic stem cell transplantation (SCT) in adults with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
    Kebriaei, P
    Kline, J
    Kasza, K
    Stock, W
    Larson, RA
    van Besien, K
    BLOOD, 2003, 102 (11) : 725A - 725A
12345